Back
Merck & Co Inc (MRK)
PharmaceuticalsMRK · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$142.38
−0.29%Weekly undervalued picks (like MRK)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$7.28
ROE
18.9%
Gross margin
76.7%
Debt/Equity
1.07x
Revenue growth
4.9%
Merck & Co Inc — company intelligence
Earnings surprises
Q2 2026$-0.13 vs $-0.27 est+52.3%
Q1 2026$-1.28 vs $-1.52 est+16.0%
Q4 2025$2.09 vs $2.03 est+3.0%
Q3 2025$2.68 vs $2.37 est+13.1%
Analyst consensus · 36 analysts
26 Buy10 Hold0 Sell
Updated Oct 8, 2026
Insider activity · 90 days
0 buys11 sellsnet -156,685 shares
Guindo ChirfiSell 10,000 · Aug 13, 2026
Zachary JenniferSell 80,315 · Aug 12, 2026
DeLuca Richard R.Sell 600 · Aug 12, 2026
Recent SEC filings
4 — Insider transaction reportOct 1, 2026
4 — Insider transaction reportOct 1, 2026
4 — Insider transaction reportOct 1, 2026
Latest news
Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA Approval — Yahoo · 2w ago
Pfizer Stock Paid Out $49B: So Why Did Investors Lose Money? — Yahoo · 2w ago
Merck remigromig DME trial results raise safety concerns — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like MRK)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.